Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2023: 6.6 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days

Cancer Drug Resistance

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

The epigenetic mechanisms involved in the treatment resistance of glioblastoma

Open Access Review DOI: 10.20517/cdr.2024.157 12 Mar 2025
Views: Downloads:
Download PDF

Antibody-drug conjugates in breast cancer treatment: resistance mechanisms and the role of therapeutic sequencing

Open Access Review DOI: 10.20517/cdr.2024.180 5 Mar 2025
Views: Downloads:
Download PDF

Sophisticated roles of tumor microenvironment in resistance to immune checkpoint blockade therapy in hepatocellular carcinoma

Open Access Review DOI: 10.20517/cdr.2024.165 25 Feb 2025
Views: Downloads:
Download PDF

Overcoming drug resistance in castrate-resistant prostate cancer: current mechanisms and emerging therapeutic approaches

Open Access Review DOI: 10.20517/cdr.2024.173 18 Feb 2025
Views: Downloads:
Download PDF

Exploring YAP1-related TIME in SCLC: implications for survival and treatment response to immuno-chemotherapy

Open Access Original Article DOI: 10.20517/cdr.2024.177 16 Feb 2025
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF

Topic: Role of Tumor Microenvironment in Cancer Drug Resistance

Submission Deadline: 19 May 2025

Published articles: 3

For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
This initiative not only recognizes the dedication of women in academia but also demonstrates our commitment to enhancing the participation of female scientists in high-impact research.
In celebration of International Women’s Day, this special collection highlights groundbreaking research from 2023 - 2024, led by female first or corresponding authors in our journal.
Authors of Review and Research Articles published in 2023-2024 have a chance to win the Best Paper Award, celebrating groundbreaking contributions to the field of cancer drug resistance.
We are pleased to announce a media partnership with the EMBO | EMBL Symposium - The ageing genome: from mechanisms to disease.
We sincerely thank all reviewers for their dedication and expertise, essential to CDR's growth and cancer drug resistance research.

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Topic: Role of Tumor Microenvironment in Cancer Drug Resistance

Submission Deadline: 19 May 2025

Published articles: 3

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/